Actio Biosciences begins trial of ABS-1230 for epilepsy
The ongoing KYRON Phase Ib/II study will examine the tolerability, pharmacokinetics, and safety of ABS-1230.
Clinical Trials
Day One concludes patient enrolment for tovorafenib’s FIREFLY-2 trial
enGene reports interim data from LEGEND trial of detalimogene voraplasmid
MEDSIR reports PHERGain and PHERGain-2 trial results for breast cancer
Taimei Technology and C&R Research to develop AI clinical trial operations platform
Patient enrolment concludes in Alebund’s Phase III trial of AP301
Oragenics opens second site for ONP-002 Phase IIa trial
Nocion completes patient enrolment in Phase IIb ASPIRE trial
